We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFRM icon
3976
Affirm
AFRM
$24.1B
$10.5K ﹤0.01%
129
-11,845
-99% -$774K
TOST icon
3977
Toast
TOST
$17.7B
$10.5K ﹤0.01%
377
-34,728
-99% -$906K
WRAP icon
3978
Wrap Technologies
WRAP
$89.6M
$10.5K ﹤0.01%
8,123
+7,349
+949% +$10.4K
HTCO
3979
High-Trend International Group
HTCO
$20.7M
$10.4K ﹤0.01%
+2,480
New +$17.5K
KLRS
3980
Kalaris Therapeutics
KLRS
$69.5M
$10.4K ﹤0.01%
2,560
+2,421
+1,742% +$12.6K
ARCT icon
3981
Arcturus Therapeutics
ARCT
$394M
$10.4K ﹤0.01%
1,550
-2,873
-65% -$22.6K
TTEC icon
3982
TTEC Holdings
TTEC
$60.6M
$10.4K ﹤0.01%
5,363
+920
+21% +$2.38K
RMNI icon
3983
Rimini Street
RMNI
$394M
$10.4K ﹤0.01%
2,442
-11,647
-83% -$44.2K
BNR
3984
Burning Rock Biotech
BNR
$196M
$10.4K ﹤0.01%
1,242
+1,214
+4,336% +$17.2K
SIGA icon
3985
SIGA Technologies
SIGA
$248M
$10.3K ﹤0.01%
2,837
+393
+16% +$1.76K
QNCX icon
3986
Quince Therapeutics
QNCX
$31.5M
$10.3K ﹤0.01%
567
+523
+1,189% +$12K
BSM icon
3987
Black Stone Minerals
BSM
$3.07B
$10.3K ﹤0.01%
737
-130
-15% -$1.81K
LZM icon
3988
Lifezone Metals
LZM
$359M
$10.2K ﹤0.01%
2,633
-3,388
-56% -$15.8K
RDZN icon
3989
Roadzen
RDZN
$119M
$10.2K ﹤0.01%
+6,996
New +$11.1K
TELA icon
3990
TELA Bio
TELA
$56.9M
$10.2K ﹤0.01%
13,612
+12,728
+1,440% +$10.4K
SUPV
3991
Grupo Supervielle
SUPV
$634M
$10.1K ﹤0.01%
1,050
+850
+425% +$7.87K
TELO icon
3992
Telomir Pharmaceuticals
TELO
$84.6M
$10.1K ﹤0.01%
+7,920
New +$10.3K
IPFX
3993
Inflection Point Acquisition Corp VI
IPFX
$339M
$10K ﹤0.01%
+971
New +$10.1K
PEPG icon
3994
PepGen
PEPG
$179M
$10K ﹤0.01%
5,557
+17
+0.3% +$28
EDSA icon
3995
Edesa Biotech
EDSA
$38.7M
$10K ﹤0.01%
1,230
+723
+143% +$6.52K
JDZG
3996
JIADE Ltd
JDZG
$23.6M
$10K ﹤0.01%
+200
New +$4.54K
SCHP icon
3997
Schwab US TIPS ETF
SCHP
$15.9B
$9.99K ﹤0.01%
+377
New +$10.1K
ZH
3998
Zhihu
ZH
$318M
$9.98K ﹤0.01%
3,188
+2,356
+283% +$7.57K
XNDU
3999
Xanadu Quantum Technologies Class B
XNDU
$1.52B
$9.98K ﹤0.01%
+824
New +$13.6K
ETHD
4000
ProShares UltraShort Ether ETF
ETHD
$44.4M
$9.94K ﹤0.01%
+107
New +$6.86K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.